VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q41347543  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000255.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q41347543‏
024 ‎‡a  0000-0003-0418-1454‏ ‎‡2  orcid‏
024 ‎‡a  7406965885‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q41347543‏
100 0 ‎‡a  Edward W. Lee‏ ‎‡9  es‏ ‎‡9  sl‏ ‎‡9  ast‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  এডওয়ার্ড ডাব্লিউ লি‏ ‎‡c  গবেষক‏ ‎‡9  bn‏
400 0 ‎‡a  Edward W. Lee‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Edward W. Lee‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A reality check in transradial access: a single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention‏
670 ‎‡a  Author's Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation‏
670 ‎‡a  Author's Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding‏
670 ‎‡a  Author's Crusted Norwegian scabies in an adult with Langerhans cell histiocytosis: mishaps leading to systemic chemotherapy‏
670 ‎‡a  Author's Diagnosis and management of upper extremity deep-vein thrombosis in adults‏
670 ‎‡a  Author's Diagnostic and interventional radiology for liver diseases‏
670 ‎‡a  Author's Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors‏
670 ‎‡a  Author's Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy‏
670 ‎‡a  Author's Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors‏
670 ‎‡a  Author's Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes.‏
670 ‎‡a  Author's Hemosuccus Pancreaticus as a Rare Complication of Bariatric Surgery‏
670 ‎‡a  Author's Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases‏
670 ‎‡a  Author's Impaired angiogenesis in neuropeptide Y‏
670 ‎‡a  Author's Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice‏
670 ‎‡a  Author's IN-1233-eluting covered metallic stent to prevent hyperplasia: experimental study in a rabbit esophageal model‏
670 ‎‡a  Author's Incidental PET/CT Detection of Breast Cancer in a Patient with Negative Mammogram and Breast Sonogram.‏
670 ‎‡a  Author's Increased expression of insulin-like growth factor in intestinal lengthening by mechanical force in rats.‏
670 ‎‡a  Author's Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques.‏
670 ‎‡a  Author's Intercostal artery pseudoaneurysm formation after irinotecan transarterial chemoembolization of a spinal metastasis from colorectal cancer‏
670 ‎‡a  Author's Irreversible Electroporation: A Novel Image-Guided Cancer Therapy‏
670 ‎‡a  Author's Irreversible electroporation: ready for prime time?‏
670 ‎‡a  Author's Is a liver biopsy necessary? Investigation of a suspected hepatocellular carcinoma: a pictorial essay of hepatocellular carcinoma and the revised American Association for the Study of Liver Disease criteria.‏
670 ‎‡a  Author's Long-term outcomes of individualized treatment strategy in treatment of type I Budd-Chiari syndrome in 456 patients‏
670 ‎‡a  Author's Lymphangiography to treat postoperative lymphatic leakage: a technical review‏
670 ‎‡a  Author's Management of hepatocellular carcinoma with portal vein thrombosis‏
670 ‎‡a  Author's Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system‏
670 ‎‡a  Author's Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the β-adrenergic system‏
670 ‎‡a  Author's Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.‏
670 ‎‡a  Author's Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?‏
670 ‎‡a  Author's Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome‏
670 ‎‡a  Author's Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization‏
670 ‎‡a  Author's Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery‏
670 ‎‡a  Author's Neuropeptide Y-induced angiogenesis in aging‏
670 ‎‡a  Author's Percutaneous ablation of hepatocellular carcinoma: current status.‏
670 ‎‡a  Author's Prophylactic Embolization of the Cystic Artery Before Radioembolization: Feasibility, Safety, and Outcomes‏
670 ‎‡a  Author's Radiation-Induced Cataractogenesis: A Critical Literature Review for the Interventional Radiologist.‏
670 ‎‡a  Author's Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma‏
670 ‎‡a  Author's Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure‏
670 ‎‡a  Author's Renal Denervation: A Novel Therapy at the Crossroads of Imaging, Intervention, and Innovation‏
670 ‎‡a  Author's Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy‏
670 ‎‡a  Author's Sinistral portal hypertension: presentation, radiological findings, and treatment options - a case report‏
670 ‎‡a  Author's Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy‏
670 ‎‡a  Author's TIPS Placement via Combined Transjugular and Transhepatic Approach for Cavernous Portal Vein Occlusion: Targeted Approach‏
670 ‎‡a  Author's Y90 selective internal radiation therapy‏
670 ‎‡a  Author's Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review‏
909 ‎‡a  (orcid) 0000000304181454‏ ‎‡9  1‏
909 ‎‡a  (scopus) 7406965885‏ ‎‡9  1‏
919 ‎‡a  realitycheckintransradialaccessasinglecentrecomparisonoftransradialandtransfemoralaccessforabdominalandperipheralintervention‏ ‎‡A  A reality check in transradial access: a single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention‏ ‎‡9  1‏
919 ‎‡a  crustednorwegianscabiesinanadultwithlangerhanscellhistiocytosismishapsleadingtosystemicchemotherapy‏ ‎‡A  Crusted Norwegian scabies in an adult with Langerhans cell histiocytosis: mishaps leading to systemic chemotherapy‏ ‎‡9  1‏
919 ‎‡a  diagnosisandmanagementofupperextremitydeepveinthrombosisinadults‏ ‎‡A  Diagnosis and management of upper extremity deep-vein thrombosis in adults‏ ‎‡9  1‏
919 ‎‡a  diagnosticandinterventionalradiologyforliverdiseases‏ ‎‡A  Diagnostic and interventional radiology for liver diseases‏ ‎‡9  1‏
919 ‎‡a  differentialeffectsofneuropeptideyonthegrowthandvascularizationofneuralcrestderivedtumors‏ ‎‡A  Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors‏ ‎‡9  1‏
919 ‎‡a  disparitiesinmortalityandhealthcareutilizationfor460851hospitalizedpatientswithcirrhosisandhepaticencephalopathy‏ ‎‡A  Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy‏ ‎‡9  1‏
919 ‎‡a  effectsofyttrium90selectiveinternalradiationtherapyonnonconventionallivertumors‏ ‎‡A  Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors‏ ‎‡9  1‏
919 ‎‡a  sinistralportalhypertensionpresentationradiologicalfindingsandtreatmentoptionsacasereport‏ ‎‡A  Sinistral portal hypertension: presentation, radiological findings, and treatment options - a case report‏ ‎‡9  1‏
919 ‎‡a  y90selectiveinternalradiationtherapy‏ ‎‡A  Y90 selective internal radiation therapy‏ ‎‡9  1‏
919 ‎‡a  tipsplacementviacombinedtransjugularandtranshepaticapproachforcavernousportalveinocclusiontargetedapproach‏ ‎‡A  TIPS Placement via Combined Transjugular and Transhepatic Approach for Cavernous Portal Vein Occlusion: Targeted Approach‏ ‎‡9  1‏
919 ‎‡a  electronmicroscopicdemonstrationandevaluationofirreversibleelectroporationinducednanoporesonhepatocytemembranes‏ ‎‡A  Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes.‏ ‎‡9  1‏
919 ‎‡a  hemosuccuspancreaticusasararecomplicationofbariatricsurgery‏ ‎‡A  Hemosuccus Pancreaticus as a Rare Complication of Bariatric Surgery‏ ‎‡9  1‏
919 ‎‡a  imageguidedhighdoseratebrachytherapypreliminaryoutcomesandtoxicityofajointinterventionalradiologyandradiationoncologytechniqueforachievinglocalcontrolinchallengingcases‏ ‎‡A  Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases‏ ‎‡9  1‏
919 ‎‡a  impairedangiogenesisinneuropeptidey‏ ‎‡A  Impaired angiogenesis in neuropeptide Y‏ ‎‡9  1‏
919 ‎‡a  impairedangiogenesisinneuropeptideynpyy2receptorknockoutmice‏ ‎‡A  Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice‏ ‎‡9  1‏
919 ‎‡a  in1233elutingcoveredmetallicstenttopreventhyperplasiaexperimentalstudyinarabbitesophagealmodel‏ ‎‡A  IN-1233-eluting covered metallic stent to prevent hyperplasia: experimental study in a rabbit esophageal model‏ ‎‡9  1‏
919 ‎‡a  incidentalpetctdetectionofbreastcancerinapatientwithnegativemammogramandbreastsonogram‏ ‎‡A  Incidental PET/CT Detection of Breast Cancer in a Patient with Negative Mammogram and Breast Sonogram.‏ ‎‡9  1‏
919 ‎‡a  increasedexpressionofinsulinlikegrowthfactorinintestinallengtheningbymechanicalforceinrats‏ ‎‡A  Increased expression of insulin-like growth factor in intestinal lengthening by mechanical force in rats.‏ ‎‡9  1‏
919 ‎‡a  inferiorvenacavafilterretrievaleffectivenessandcomplicationsofroutineandadvancedtechniques‏ ‎‡A  Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques.‏ ‎‡9  1‏
919 ‎‡a  intercostalarterypseudoaneurysmformationafteririnotecantransarterialchemoembolizationofaspinalmetastasisfromcolorectalcancer‏ ‎‡A  Intercostal artery pseudoaneurysm formation after irinotecan transarterial chemoembolization of a spinal metastasis from colorectal cancer‏ ‎‡9  1‏
919 ‎‡a  irreversibleelectroporationanovelimageguidedcancertherapy‏ ‎‡A  Irreversible Electroporation: A Novel Image-Guided Cancer Therapy‏ ‎‡9  1‏
919 ‎‡a  irreversibleelectroporationreadyforprimetime‏ ‎‡A  Irreversible electroporation: ready for prime time?‏ ‎‡9  1‏
919 ‎‡a  retrogradetransvenousobliterationrtoanewtreatmentoptionforhepaticencephalopathy‏ ‎‡A  Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy‏ ‎‡9  1‏
919 ‎‡a  isaliverbiopsynecessaryinvestigationofasuspectedhepatocellularcarcinomaapictorialessayofhepatocellularcarcinomaandtherevisedamericanassociationforthestudyofliverdiseasecriteria‏ ‎‡A  Is a liver biopsy necessary? Investigation of a suspected hepatocellular carcinoma: a pictorial essay of hepatocellular carcinoma and the revised American Association for the Study of Liver Disease criteria.‏ ‎‡9  1‏
919 ‎‡a  renaldenervationanoveltherapyatthecrossroadsofimaginginterventionandinnovation‏ ‎‡A  Renal Denervation: A Novel Therapy at the Crossroads of Imaging, Intervention, and Innovation‏ ‎‡9  1‏
919 ‎‡a  renalandcardiacneuropeptideyandnpyreceptorsinaratmodelofcongestiveheartfailure‏ ‎‡A  Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure‏ ‎‡9  1‏
919 ‎‡a  recentadvancesintransarterialembolotherapiesinthetreatmentofhepatocellularcarcinoma‏ ‎‡A  Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma‏ ‎‡9  1‏
919 ‎‡a  radiationinducedcataractogenesisacriticalliteraturereviewfortheinterventionalradiologist‏ ‎‡A  Radiation-Induced Cataractogenesis: A Critical Literature Review for the Interventional Radiologist.‏ ‎‡9  1‏
919 ‎‡a  prophylacticembolizationofthecysticarterybeforeradioembolizationfeasibilitysafetyandoutcomes‏ ‎‡A  Prophylactic Embolization of the Cystic Artery Before Radioembolization: Feasibility, Safety, and Outcomes‏ ‎‡9  1‏
919 ‎‡a  percutaneousablationofhepatocellularcarcinomacurrentstatus‏ ‎‡A  Percutaneous ablation of hepatocellular carcinoma: current status.‏ ‎‡9  1‏
919 ‎‡a  longtermoutcomesofindividualizedtreatmentstrategyintreatmentoftype1buddchiarisyndromein456patients‏ ‎‡A  Long-term outcomes of individualized treatment strategy in treatment of type I Budd-Chiari syndrome in 456 patients‏ ‎‡9  1‏
919 ‎‡a  lymphangiographytotreatpostoperativelymphaticleakageatechnicalreview‏ ‎‡A  Lymphangiography to treat postoperative lymphatic leakage: a technical review‏ ‎‡9  1‏
919 ‎‡a  managementofhepatocellularcarcinomawithportalveinthrombosis‏ ‎‡A  Management of hepatocellular carcinoma with portal vein thrombosis‏ ‎‡9  1‏
919 ‎‡a  mitogenicactionsofneuropeptideyinvascularsmoothmusclecellssynergeticinteractionswiththebetaadrenergicsystem‏ ‎‡A  Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system‏ ‎‡9  1‏
919 ‎‡a  mitogenicactionsofneuropeptideyinvascularsmoothmusclecellssynergeticinteractionswiththeβadrenergicsystem‏ ‎‡A  Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the β-adrenergic system‏ ‎‡9  1‏
919 ‎‡a  nationwidetrendsandpredictorsofinpatientmortalityin83884transjugularintrahepaticportosystemicshunt‏ ‎‡A  Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.‏ ‎‡9  1‏
919 ‎‡a  neuropeptideyanewmediatorlinkingsympatheticnervesbloodvesselsandimmunesystem‏ ‎‡A  Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?‏ ‎‡9  1‏
919 ‎‡a  neuropeptideyactsdirectlyintheperipheryonfattissueandmediatesstressinducedobesityandmetabolicsyndrome‏ ‎‡A  Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome‏ ‎‡9  1‏
919 ‎‡a  neuropeptideyandy2receptorareinvolvedindevelopmentofdiabeticretinopathyandretinalneovascularization‏ ‎‡A  Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization‏ ‎‡9  1‏
919 ‎‡a  neuropeptideyinducedangiogenesisinaging‏ ‎‡A  Neuropeptide Y-induced angiogenesis in aging‏ ‎‡9  1‏
919 ‎‡a  neuropeptideyinducedaccelerationofpostangioplastyocclusionofratcarotidartery‏ ‎‡A  Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery‏ ‎‡9  1‏
919 ‎‡a  therapymodelforadvancedintracerebralb16mousemelanomausingradiationtherapycombinedwithimmunotherapy‏ ‎‡A  Therapy model for advanced intracerebral B16 mouse melanoma using radiation therapy combined with immunotherapy‏ ‎‡9  1‏
919 ‎‡a  yttrium90selectiveinternalradiationtherapywithglassmicrospheresforhepatocellularcarcinomacurrentandupdatedliteraturereview‏ ‎‡A  Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review‏ ‎‡9  1‏
919 ‎‡a  criticalroleofdipeptidylpeptidase4inneuropeptideymediatedendothelialcellmigrationinresponsetowounding‏ ‎‡A  Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding‏ ‎‡9  1‏
919 ‎‡a  advancedhepaticablationtechniqueforcreatingcompletecelldeathirreversibleelectroporation‏ ‎‡A  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  LC|n 87891782‏
996 ‎‡2  DNB|173604773‏
996 ‎‡2  ISNI|0000000493173137‏
996 ‎‡2  BIBSYS|90921550‏
996 ‎‡2  SUDOC|262491338‏
996 ‎‡2  ISNI|0000000049387358‏
996 ‎‡2  NUKAT|n 2016052880‏
996 ‎‡2  ISNI|0000000120942730‏
996 ‎‡2  NTA|370478525‏
996 ‎‡2  LC|n 2006021895‏
996 ‎‡2  LIH|LNB:B_j__n_,;=B1‏
996 ‎‡2  NII|DA19520549‏
996 ‎‡2  BNC|981058521198306706‏
996 ‎‡2  NLA|000035222926‏
996 ‎‡2  J9U|987007281186205171‏
996 ‎‡2  LC|no2016163544‏
996 ‎‡2  ISNI|0000000440151241‏
996 ‎‡2  BIBSYS|90060678‏
996 ‎‡2  ISNI|000000048394898X‏
996 ‎‡2  NTA|339744510‏
996 ‎‡2  ISNI|0000000500924868‏
996 ‎‡2  ISNI|0000000508119177‏
996 ‎‡2  LC|n 80047241‏
996 ‎‡2  ISNI|0000000513671118‏
996 ‎‡2  J9U|987007276142905171‏
996 ‎‡2  NLB|18607101‏
996 ‎‡2  BNCHL|10000000000000000260093‏
996 ‎‡2  LC|n 85198525‏
996 ‎‡2  ISNI|0000000040914756‏
996 ‎‡2  ISNI|0000000081156971‏
996 ‎‡2  CAOONL|ncf12056062‏
996 ‎‡2  ISNI|0000000476969125‏
996 ‎‡2  ISNI|0000000385857793‏
996 ‎‡2  SUDOC|249033992‏
996 ‎‡2  ISNI|0000000041508899‏
996 ‎‡2  LC|no 98096339‏
996 ‎‡2  NYNYRILM|304645‏
996 ‎‡2  DNB|1233733044‏
996 ‎‡2  LC|n 2022035163‏
996 ‎‡2  SUDOC|146567056‏
996 ‎‡2  RERO|A011433213‏
996 ‎‡2  LC|no2023126475‏
996 ‎‡2  NTA|273410393‏
996 ‎‡2  LC|n 2011018097‏
996 ‎‡2  NII|DA15036817‏
996 ‎‡2  NLA|000035078374‏
996 ‎‡2  LC|no2001025958‏
996 ‎‡2  LC|nr 94043069‏
996 ‎‡2  ISNI|000000049772387X‏
996 ‎‡2  ISNI|0000000068344468‏
996 ‎‡2  CAOONL|ncf10436933‏
996 ‎‡2  BNF|13332259‏
996 ‎‡2  DNB|1055154442‏
996 ‎‡2  NTA|07294515X‏
996 ‎‡2  ISNI|000000049404605X‏
996 ‎‡2  SZ|1055748504‏
996 ‎‡2  NUKAT|n 2019105049‏
996 ‎‡2  SUDOC|204486734‏
996 ‎‡2  DNB|133368106‏
996 ‎‡2  BNC|981058521105806706‏
996 ‎‡2  RERO|A006604416‏
996 ‎‡2  ISNI|000000004380144X‏
996 ‎‡2  LC|n 2004036012‏
996 ‎‡2  LC|no2016075447‏
996 ‎‡2  NTA|369440501‏
996 ‎‡2  N6I|vtls000281313‏
996 ‎‡2  LC|n 97043676‏
996 ‎‡2  NTA|30436620X‏
996 ‎‡2  LC|n 82140800‏
996 ‎‡2  ISNI|000000011878768X‏
996 ‎‡2  BIBSYS|13052704‏
996 ‎‡2  LC|no2010175753‏
996 ‎‡2  LC|no2019097149‏
996 ‎‡2  DNB|1056135166‏
996 ‎‡2  BIBSYS|90960393‏
996 ‎‡2  SUDOC|164302492‏
996 ‎‡2  ISNI|0000000492145169‏
996 ‎‡2  LC|n 93028841‏
996 ‎‡2  LC|n 2004022410‏
996 ‎‡2  ISNI|0000000114451388‏
996 ‎‡2  ISNI|0000000407765014‏
996 ‎‡2  SZ|119154811‏
996 ‎‡2  ISNI|0000000118556099‏
996 ‎‡2  DNB|1055748504‏
996 ‎‡2  LC|n 83210808‏
996 ‎‡2  NUKAT|n 2011220836‏
996 ‎‡2  DNB|129240923‏
996 ‎‡2  SUDOC|185331246‏
996 ‎‡2  BNE|XX4856120‏
996 ‎‡2  LC|no2020130252‏
996 ‎‡2  LC|no2017153850‏
996 ‎‡2  PLWABN|9813703829105606‏
996 ‎‡2  NDL|031224382‏
996 ‎‡2  ISNI|0000000500474692‏
996 ‎‡2  BNCHL|10000000000000000211723‏
996 ‎‡2  LC|no2024002219‏
996 ‎‡2  LC|n 2004079635‏
996 ‎‡2  NTA|191250198‏
996 ‎‡2  J9U|987011218087905171‏
996 ‎‡2  RERO|A003507133‏
996 ‎‡2  LC|no2003069451‏
996 ‎‡2  ISNI|0000000439998007‏
996 ‎‡2  N6I|vtls000055255‏
996 ‎‡2  CAOONL|ncf10601000‏
996 ‎‡2  PLWABN|9810689479805606‏
996 ‎‡2  LC|no2006104239‏
996 ‎‡2  J9U|987007391790305171‏
996 ‎‡2  J9U|987009347707605171‏
996 ‎‡2  ISNI|0000000045193935‏
996 ‎‡2  LC|no2016146657‏
996 ‎‡2  BIBSYS|90353774‏
996 ‎‡2  CAOONL|ncf11274791‏
996 ‎‡2  ISNI|0000000025799518‏
996 ‎‡2  LC|n 79104037‏
996 ‎‡2  JPG|500269653‏
996 ‎‡2  LC|n 86024332‏
996 ‎‡2  ISNI|0000000037599310‏
996 ‎‡2  J9U|987007447975205171‏
996 ‎‡2  NTA|067613829‏
996 ‎‡2  PTBNP|1863571‏
996 ‎‡2  ISNI|000000004900170X‏
996 ‎‡2  NII|DA10915978‏
996 ‎‡2  ISNI|0000000118295925‏
996 ‎‡2  ISNI|0000000075052922‏
996 ‎‡2  NLB|18700593‏
996 ‎‡2  NTA|073909521‏
996 ‎‡2  ISNI|0000000026684560‏
996 ‎‡2  BNF|16382816‏
996 ‎‡2  LC|no2001071150‏
996 ‎‡2  ISNI|0000000425089283‏
996 ‎‡2  LC|n 2014068875‏
996 ‎‡2  NTA|086371568‏
996 ‎‡2  NTA|413336212‏
996 ‎‡2  SUDOC|195423364‏
996 ‎‡2  ISNI|0000000479210579‏
996 ‎‡2  LC|nb2011015500‏
996 ‎‡2  SUDOC|180217348‏
996 ‎‡2  ISNI|0000000051288105‏
996 ‎‡2  SZ|1016401701‏
996 ‎‡2  ISNI|000000003278295X‏
996 ‎‡2  BAV|495_371265‏
996 ‎‡2  BIBSYS|90659286‏
996 ‎‡2  LC|no 00008592‏
996 ‎‡2  NDL|001176366‏
996 ‎‡2  LC|no 98097219‏
996 ‎‡2  KRNLK|KAC199616227‏
996 ‎‡2  DNB|1157374778‏
996 ‎‡2  LC|no2015118361‏
996 ‎‡2  ISNI|0000000078925151‏
996 ‎‡2  SUDOC|031392636‏
996 ‎‡2  NDL|00447182‏
996 ‎‡2  NTA|096166673‏
996 ‎‡2  NTA|072765380‏
996 ‎‡2  BAV|495_150842‏
996 ‎‡2  ISNI|000000004114938X‏
996 ‎‡2  DNB|131673289‏
996 ‎‡2  ISNI|0000000108143813‏
996 ‎‡2  LC|n 99031302‏
996 ‎‡2  ISNI|0000000038271376‏
996 ‎‡2  DNB|141182393‏
996 ‎‡2  LC|n 84153508‏
996 ‎‡2  BNC|981058616698406706‏
996 ‎‡2  PLWABN|9810661416605606‏
996 ‎‡2  BNF|12261573‏
996 ‎‡2  ISNI|0000000108150036‏
996 ‎‡2  SUDOC|030963982‏
996 ‎‡2  NII|DA05712814‏
996 ‎‡2  BNF|13743595‏
996 ‎‡2  BIBSYS|90526432‏
996 ‎‡2  BNF|17867971‏
996 ‎‡2  SUDOC|033225478‏
996 ‎‡2  LC|n 97800474‏
996 ‎‡2  BNF|16539751‏
996 ‎‡2  NUKAT|n 2015201240‏
996 ‎‡2  BNF|12227492‏
996 ‎‡2  NUKAT|n 00024963‏
996 ‎‡2  BNF|12481001‏
996 ‎‡2  DNB|189570369‏
996 ‎‡2  BNE|XX929665‏
996 ‎‡2  BNF|12765621‏
996 ‎‡2  ISNI|0000000497884999‏
996 ‎‡2  DNB|1115813242‏
996 ‎‡2  ISNI|0000000046391546‏
996 ‎‡2  BNC|981060922702106706‏
996 ‎‡2  CAOONL|ncf10299698‏
996 ‎‡2  NII|DA13216829‏
996 ‎‡2  LC|no 95058052‏
996 ‎‡2  RERO|A016255500‏
996 ‎‡2  DNB|1013404505‏
996 ‎‡2  LC|n 2012071917‏
996 ‎‡2  LC|no2019168883‏
996 ‎‡2  BIBSYS|90386769‏
996 ‎‡2  LC|no2021071853‏
996 ‎‡2  NKC|mub2017943516‏
996 ‎‡2  DBC|87097991344769‏
996 ‎‡2  ISNI|0000000491682341‏
996 ‎‡2  NTA|073573582‏
996 ‎‡2  CAOONL|ncf11881775‏
996 ‎‡2  LC|no2014002692‏
996 ‎‡2  LC|n 2014068009‏
996 ‎‡2  NKC|xx0207433‏
996 ‎‡2  NII|DA02611923‏
996 ‎‡2  NII|DA05907642‏
996 ‎‡2  ISNI|0000000069502683‏
996 ‎‡2  SUDOC|252771206‏
996 ‎‡2  BIBSYS|8023917‏
996 ‎‡2  DNB|1197647759‏
996 ‎‡2  BIBSYS|4088313‏
996 ‎‡2  LC|no 95038168‏
996 ‎‡2  NUKAT|n 2016146182‏
996 ‎‡2  NUKAT|n 2019201306‏
996 ‎‡2  NUKAT|n 2011203451‏
996 ‎‡2  NSK|000625248‏
996 ‎‡2  ISNI|0000000047212730‏
996 ‎‡2  DNB|1105699838‏
996 ‎‡2  NKC|ntk20211108239‏
996 ‎‡2  PTBNP|1379918‏
996 ‎‡2  BAV|495_209358‏
996 ‎‡2  ISNI|0000000491676865‏
996 ‎‡2  LC|n 90720843‏
996 ‎‡2  ISNI|0000000074515569‏
996 ‎‡2  KRNLK|KAC200907471‏
996 ‎‡2  J9U|987007457262305171‏
996 ‎‡2  BIBSYS|7065555‏
996 ‎‡2  BAV|495_209357‏
996 ‎‡2  JPG|500450179‏
996 ‎‡2  ISNI|0000000065434687‏
996 ‎‡2  J9U|987007446154705171‏
996 ‎‡2  N6I|vtls000044231‏
996 ‎‡2  NTA|412514281‏
996 ‎‡2  BNF|16973249‏
996 ‎‡2  SUDOC|271283378‏
996 ‎‡2  LC|no2019135743‏
996 ‎‡2  LC|n 97005122‏
996 ‎‡2  NUKAT|n 98041950‏
996 ‎‡2  ISNI|0000000083888439‏
996 ‎‡2  J9U|987007422259405171‏
996 ‎‡2  BIBSYS|90391956‏
996 ‎‡2  RERO|A003507138‏
996 ‎‡2  RERO|A003507136‏
996 ‎‡2  RERO|A003507137‏
996 ‎‡2  RERO|A003507135‏
996 ‎‡2  LC|n 2002079857‏
996 ‎‡2  ISNI|0000000045838393‏
996 ‎‡2  NTA|146942388‏
996 ‎‡2  LC|n 85216125‏
996 ‎‡2  LC|nb2011007566‏
996 ‎‡2  SUDOC|152852697‏
996 ‎‡2  NTA|257374949‏
996 ‎‡2  LC|nb2007005320‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏